How Does the Body Make GLP-1?

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Your body manufactures glucagon-like peptide-1 (GLP-1) in specialized intestinal cells called L-cells, which line your small bowel and release this hormone after you eat. The amount your body produces varies based on genetics, diet, and metabolic health—and some people naturally make significantly less than others. Understanding your GLP-1 production capacity is the first step toward choosing the right weight loss strategy.

Where Your Body Produces GLP-1 Naturally

Intestinal L-cells, found primarily in your ileum and colon, manufacture and secrete GLP-1 whenever nutrients enter your digestive system. These cells detect glucose, amino acids, and fatty acids, then release GLP-1 directly into your bloodstream within minutes of eating. The response is automatic—your body has been performing this process since birth, adjusting meal to meal based on what you consume.

L-cells also line your stomach and upper small intestine, creating a distributed network that monitors your entire digestive tract. When food triggers L-cell activation, GLP-1 levels can increase 5- to 10-fold in healthy individuals, though this response weakens in people with obesity or type 2 diabetes. This natural hormone acts as a metabolic messenger, telling your brain you're full and signaling your pancreas to release insulin appropriately.

Why Some People Produce Less GLP-1

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to GLP-1 medications or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Beyond genetics, obesity itself reduces GLP-1 secretion in a harmful cycle: excess weight dampens L-cell function, lowering hormone production, which allows more overeating, which perpetuates weight gain. Poor diet quality, sedentary behavior, and inflammation also suppress natural GLP-1 responses, making it harder for your body to signal fullness. This is why some individuals struggle with weight loss despite significant effort—their endogenous GLP-1 system is simply underperforming.

The PlexusDx Precision Peptide Genetic Test identifies variants in your GLP1R gene and 13 other metabolic pathways, revealing whether your natural GLP-1 production capacity is genetically optimized or compromised. This insight helps confirm whether GLP-1 therapy is strategically appropriate for your biology, rather than guessing based on trial and error.

How GLP-1 Therapy Restores What Your Body Isn't Making

Semaglutide, the active compound in PlexusDx injectable therapy, mimics the GLP-1 your intestines produce naturally but delivers a consistent, therapeutic dose your body cannot generate on its own. Rather than replacing your natural system, semaglutide supplements insufficient endogenous production, essentially providing the appetite control and metabolic signaling your L-cells should be delivering. Starting at $149 per month with no flat per-compound pricing increases, PlexusDx semaglutide injection compensates for genetic or metabolic deficiency in your GLP-1 pathway.

The hormone works through the same receptors your natural GLP-1 targets—slowing gastric emptying so food stays in your stomach longer, increasing satiety signals to your brain, and improving how your body handles blood glucose. Clinical trials show semaglutide users experience sustained weight loss averaging 10-15% of body weight over 68 weeks, with effects persisting as long as therapy continues. Your dose may need to go up to match your individual tolerance and weight loss goals, but your monthly price stays flat—PlexusDx's commitment to transparent, non-punitive dosing.

Unlike fad diets or willpower-dependent strategies, semaglutide therapy addresses the root biological problem: insufficient GLP-1 signaling. By restoring this missing hormonal feedback, you regain normal hunger cues, reduce cravings, and achieve calorie deficit without the constant psychological strain of fighting your own metabolism.

Choosing Between Injectable and Oral GLP-1 Therapy

PlexusDx offers compounded semaglutide in two delivery forms: injectable (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and oral (at $289/mo month-to-month, or from $249/mo on the 6-month plan). Injectable semaglutide is absorbed directly into the bloodstream through subcutaneous tissue, providing predictable, high bioavailability and consistent GLP-1 receptor activation. Oral semaglutide must survive stomach acid and intestinal digestion, requiring larger doses and sometimes less reliable absorption—which is why oral pricing begins higher despite comparable clinical outcomes in committed users.

Both forms are manufactured by licensed 503A compounding pharmacies and available nationwide with no insurance requirement or membership fee. Your choice depends on injection comfort, convenience, and cost preference. HSA and FSA accounts cover both options, making PlexusDx therapy accessible whether you have traditional insurance or not. A qualified PlexusDx clinician will help you select the delivery method that aligns with your lifestyle and metabolic goals during your initial consultation.

Genetic Testing and Personalized GLP-1 Selection

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is GLP-1, and why does my body make it?

GLP-1 is a hormone your intestinal L-cells produce after eating to signal fullness, slow digestion, and regulate blood sugar. Your body manufactures it automatically to prevent overeating and maintain metabolic balance—but some people genetically produce less, contributing to weight gain and hunger dysregulation.

Can I increase my natural GLP-1 production without medication?

Diet changes—especially high-protein, high-fiber meals—can modestly improve L-cell GLP-1 secretion, and weight loss itself restores natural hormone responsiveness. However, if your GLP1R gene carries loss-of-function variants, your maximum natural output may always be insufficient, making semaglutide therapy a more reliable solution.

How much does PlexusDx semaglutide cost, and is it covered by insurance?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no flat per-compound pricing increases—your dose may go up, but your price won't. The therapy is available nationwide without insurance, and HSA/FSA accounts are eligible for reimbursement.

Is compounded semaglutide as safe and effective as brand-name Ozempic?

PlexusDx semaglutide is manufactured by licensed 503A compounding pharmacies under stringent quality and sterility standards. While not FDA-approved as a finished drug, compounded semaglutide demonstrates equivalent clinical outcomes to brand versions when sourced from credible pharmacies, at significantly lower cost.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. The test identifies your GLP1R gene variants and 48 other peptide-pathway markers, revealing whether your natural GLP-1 deficit is genetic and predicting your likelihood of strong semaglutide response. Results guide whether semaglutide alone or dual-compound therapy suits your biology best.

Related Reading

• Maximus Glp 1
• Found Glp 1
• Orderly Meds Glp 1
• Henry Meds Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.